CD73-IN-13

• UNSPSC Description:

  CD73-IN-13 is a potent inhibitor of CD73. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-13 be used for preparing a medicament for tumor-related diseases (extracted from patent CN114437039A, compound 7)[1].

• Target Antigen:

  CD73

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cd73-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=NN=C(C=C1[C@H]2C[C@@H]2C(F)(F)F)C3=CNC(NC3=O)=O

• Molecular Weight:

  312.25

• References & Citations:

  [1]Xuejun Zhang, et al. Pyridazine alkyne compound and application thereof. Patent CN114437039A.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2773423-69-9